Compile Data Set for Download or QSAR
Report error Found 64 Enz. Inhib. hit(s) with all data for entry = 10507
TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542437(1-[4-(4-fluorophenyl)-2-pyrazol-1-yl-cyclopentyl] ...)
Affinity DataIC50: 2.80nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542002(1-[4-(4-fluorophenyl)-2-(triazol-2-yl)cyclopentyl]...)
Affinity DataIC50: 3.37nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542439(5-fluoro-1-[4-(4-fluorophenyl)-2-pyrazol-1-yl-cycl...)
Affinity DataIC50: 3.40nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542462(5-fluoro-1-[4-(4-fluorophenyl)-2-pyrimidin-4-yloxy...)
Affinity DataIC50: 3.44nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542462(5-fluoro-1-[4-(4-fluorophenyl)-2-pyrimidin-4-yloxy...)
Affinity DataIC50: 3.68nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542143(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 3.78nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542444(5-fluoro-1-[4-(4-fluorophenyl)-2-(tetrazol-2-yl) c...)
Affinity DataIC50: 4.03nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542199(1-[2-(3-amino-5-fluoro-1-piperidyl)-4-(4-fluorophe...)
Affinity DataIC50: 4.06nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542143(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 4.28nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542121(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 5.31nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542121(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 5.39nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542199(1-[2-(3-amino-5-fluoro-1-piperidyl)-4-(4-fluorophe...)
Affinity DataIC50: 6.22nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542456(1-[2-(4-chloropyridazin-3-yl)oxy-4-(4-fluorophenyl...)
Affinity DataIC50: 6.56nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542439(5-fluoro-1-[4-(4-fluorophenyl)-2-pyrazol-1-yl-cycl...)
Affinity DataIC50: 6.64nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542446(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 7.10nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542457(6-[2-(3-amino-5-fluoro-1-piperidyl)-4-(4-fluorophe...)
Affinity DataIC50: 7.20nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542445(1-[4-(4-fluorophenyl)-2-(tetrazol-2-yl)cyclopentyl...)
Affinity DataIC50: 7.55nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542437(1-[4-(4-fluorophenyl)-2-pyrazol-1-yl-cyclopentyl] ...)
Affinity DataIC50: 7.97nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542111(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 7.97nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542111(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 8.31nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542448(4-[2-(3-amino-1-piperidyl)-4-(4-fluoro-3-methoxy-p...)
Affinity DataIC50: 9.51nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542459(6-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 9.51nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542458(l-[4-(4-fluorophenyl)-2-(5-fluoropyridazin-3-yl)ox...)
Affinity DataIC50: 9.93nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542444(5-fluoro-1-[4-(4-fluorophenyl)-2-(tetrazol-2-yl) c...)
Affinity DataIC50: 10.6nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542465(5-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 10.6nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542456(1-[2-(4-chloropyridazin-3-yl)oxy-4-(4-fluorophenyl...)
Affinity DataIC50: 11.3nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542463(2-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 11.5nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542457(6-[2-(3-amino-5-fluoro-1-piperidyl)-4-(4-fluorophe...)
Affinity DataIC50: 11.8nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542464(5-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 13.7nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542453(2-[2-(3-amino-1-piperidyl)-4-phenyl-cyclopentoxy] ...)
Affinity DataIC50: 14.1nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542446(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 14.3nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542443(5-fluoro-1-[4-(4-fluorophenyl)-2-(1,2,4-triazol-1-...)
Affinity DataIC50: 16nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542201(1-[2-(3-amino-4,4-difluoro-1-piperidyl)-4-(4-fluor...)
Affinity DataIC50: 16.2nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542454(4-[2-(3-amino-1-piperidyl)-4-phenyl-cyclopentoxy]-...)
Affinity DataIC50: 17.4nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542447(4-[2-(3-amino-1-piperidyl)-4-(4-fluoro-3-hydroxy-p...)
Affinity DataIC50: 17.4nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542201(1-[2-(3-amino-4,4-difluoro-1-piperidyl)-4-(4-fluor...)
Affinity DataIC50: 17.5nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542002(1-[4-(4-fluorophenyl)-2-(triazol-2-yl)cyclopentyl]...)
Affinity DataIC50: 17.7nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542461(1-[4-(4-fluorophenyl)-2-pyridazin-3-yloxy-cyclopen...)
Affinity DataIC50: 17.8nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542449(4-[2-(3-amino-1-piperidyl)-4-(3-fluorophenyl) cycl...)
Affinity DataIC50: 19.3nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542119(1-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl)cyclo...)
Affinity DataIC50: 19.9nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542450(4-[2-(3-amino-4,4-difluoro-1-piperidyl)-4-(4-fluor...)
Affinity DataIC50: 20.7nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542460(6-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 22nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542448(4-[2-(3-amino-1-piperidyl)-4-(4-fluoro-3-methoxy-p...)
Affinity DataIC50: 22.5nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542463(2-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 24nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542452(4-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 25.1nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542464(5-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 25.5nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 3(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542459(6-[2-(3-amino-1-piperidyl)-4-(4-fluorophenyl) cycl...)
Affinity DataIC50: 25.5nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542445(1-[4-(4-fluorophenyl)-2-(tetrazol-2-yl)cyclopentyl...)
Affinity DataIC50: 26.7nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542455(6-[2-(3-amino-5-fluoro-1-piperidyl)-4-(4-fluorophe...)
Affinity DataIC50: 28.8nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

TargetShort transient receptor potential channel 6(Human)
Dizal (Jiangsu) Pharmaceutical

US Patent
LigandPNGBDBM542443(5-fluoro-1-[4-(4-fluorophenyl)-2-(1,2,4-triazol-1-...)
Affinity DataIC50: 29.8nMAssay Description:For TRPC6 current recording, the intracellular solution contained (in mM): 120 CsOH, 120 Aspartate, 20 CsCl, 2 MgCl2, 0.4 CaCl2, 10 HEPES, 2 Na2ATP, ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/4/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 64 total ) | Next | Last >>
Jump to: